Abaxis, Inc. to Present at the UBS Global Life Sciences Conference
UNION CITY, Calif., Sept. 16 Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 12:00 p.m. ET. The conference will be held at the Grand Hyatt New York Hotel in New York City.
Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.
Contact: Clint Severson Lytham Partners, LLC Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum ABAXIS, Inc. 602-889-9700 510-675-6500
SOURCE Abaxis, Inc.
You May Also Like